Baskadia

Elsevier's 2023 Intravenous Medications. Shelly Rainforth Collins PharmD

Elsevier-s-2023-Intravenous.pdf
ISBN: 9780323931809 | 1392 pages | 24 Mb

• Elsevier's 2023 Intravenous Medications
  

• Shelly Rainforth Collins PharmD
  

• Page: 1392
  

• Format: pdf, ePub, fb2, mobi
  

• ISBN: 9780323931809
  

• Publisher: Elsevier Health Sciences
  

Download Elsevier's 2023 Intravenous Medications

Download english book for mobile Elsevier's 2023 Intravenous Medications

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2023 edition are 10 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference. Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more. Additional drug monographs are provided on the Evolve website. Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks. Blue-screened text calls attention to special circumstances not covered by Black Box Warnings. Dosage and dilution charts within monographs provide quick summaries of essential clinical information. Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. Convenient, A-to-Z format organizes all drug monographs by generic name, allowing students to find any drug in seconds. Spiral binding allows the book to lie flat, leaving the practitioner’s hands free to perform other tasks. NEW! Drug monographs for 10 newly approved drugs by the FDA include the most current information. NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications.

Book Detail 9780323931809 - Elsevier's 2023 Intravenous
New to the 2023 edition are 10 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, 
eBook: Elsevier's 2023 Intravenous Medications - E-Book von
New to the 2023 edition are 10 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, 
Elsevier's 2023 Intravenous Medications - Booktopia
New to the 2023 edition are 10 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, 
Elsevier's 2023 Intravenous Medications - Lehmanns Media
New to the 2023 edition are nine monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, 
Elsevier's 2023 Intravenous Medications - Shelly Rainforth - Adlibris
Pris: 423 kr. spiral, 2022. Ännu ej utkommen. Köp boken Elsevier's 2023 Intravenous Medications av Shelly Rainforth Collins (ISBN 9780323931809) hos 
Elsevier's 2023 Intravenous Medications by Shelly Rainforth
Elsevier's 2023 Intravenous Medications book. Read reviews from world's largest community for readers. Find the essential information you need to safely
Pharmacology Core Titles - Rittenhouse Book Distributors
Collins: Elsevier's 2023 Intravenous Medications ; ISBN 13: 9780323931809. Edition: 39. Publisher: Elsevier Health Science. Publication Date: 06/2022. Doody's 
Elsevier's 2023 Intravenous Medications - Lehmanns Media
New to the 2023 edition are nine monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions,